Data Cart

Your data extract

0 variables
0 event summary variables
0 samples
View Cart

Description

For all medication-round fills, except for drugs determined to be a confidentiality risk (see below), RXNDC reports the National Drug Code (NDC) of the prescribed medicine. The NDC is provided during the pharmacy component of the MEPS survey. In cases where the NDC provided by the pharmacy is not valid, a secondary data source is used to impute a valid value for that prescribed medicine. See the comparability tab for more information about how these cases are handled over time. See also RXNAME and RXDRGNAM for additional information about prescribed medication-round fill attributes.

In most cases, each prescribed medicine is associated with one RXNDC value, however, each fill of a prescribed medicine can have a unique RXNDC value in cases where the medication's form, strength, manufacturer, or package size differ across fills. Thus, a prescribed medicine may have only been reported once in the household component but may be represented by multiple medication-round fills with unique RXNDC values in the data.

For 1996-2008 samples, RXNDC was used to link drugs across rounds. Beginning in 2009, DRUGID was introduced as the "prescribed medicine drug-level ID" and replaced RXNDC as the variable used to link drugs over time. See DRUGID for more information about linking drugs across MEPS rounds and see MEPSDRUGID for more information about linking drugs across MEPS panels.

A drug can pose a confidentiality risk for several reasons. Examples include orphan drugs, drugs that are estimated to be used by fewer than 200,000 people, or drug names that provide identifying information about the pharmacy or respondent. An orphan drug is a drug that treats a rare disease or condition but has been discontinued because there is little or no economic incentive to continue development or production. See Rare Diseases at the FDA for more information about how these drugs are designated and the effort to financially support their development and production under the Orphan Drug Act. See the codes tab for more detailed information about how cases that pose a confidentiality risk are handled in the data.

IPUMS MEPS reports the universe for each variable based on a thorough review of the original MEPS documentation. Investigating the data may reveal cases that do not meet the stated universe. Users are encouraged to validate universes for their analyses.

RXNDC is on the medication-round fill record (see RECTYPE for more details on the different record types in IPUMS MEPS). Variables offered on the medication-round fill record through IPUMS MEPS are derived from the prescribed medicines file provided by AHRQ. Please see our overview of the event, medical conditions, and prescribed medicines variables, including how those variables are offered through IPUMS MEPS, and general considerations to keep in mind when conducting analyses using these variables.